Sidebar
Dec 2009

Time for pharma marketing to take it up in 2010

iStock_000010684597XSmall
2010 is almost here and a lot of people will be trying to get back into the groove of going back to work after a lengthy holiday break. Will it be more of the same ol' same ol' or will there be an effort to think of new ways to interact with empowered patients and consumers who mistrust big business ? Here are some ways to take it up a notch in 2010.
Read More...
|

2010: Where does pharma marketing go from here ?

me349
There's no doubt that consumers have changed their behavior as a result of the recent recession. Some marketers believe that that it's temporary but I think the Internet and mistrust in big pharma is redefining how consumers approach and think about healthcare. The key issue now ? Will DTC marketers and the drug industry change the way they market to consumers or will they continue down the same path as before as the wait for the FDA to issue guidelines ? Click here to download my presentation called "Where do we go from here"

Read More...
|

Who do consumers trust when it comes to healthcare?

images
Trust. It's a small word but it means so much to consumers today and it's getting harder to earn and keep, especially when consumers keep reading bad stories about our industry in the media. A recent Gallup poll indicated that consumers trust pharmacists and nurses more than doctors. As if physicians didn't have enough to worry about.. Read More...
|

Mobile marketing, the next wave to come crashing to shore

images-1
Mobile Marketing is getting ready to explode next year but marketers who apply old marketing to a new channel are quickly going to learn that their efforts are going to waste. If you want to leverage mobile marketing you need to thing apps, integration is user and business needs and evolution. Read More...
|

What do eHealth consumers want from social media?

images
We're still analyzing the final report from our recently completed research with eHealth consumers but with 35% of consumers starting their health searches on social media we wanted to know exactly what they expected to find. We found that people want to connect with others who have similar experiences and want advice on how to live a more normal life with a health condition or disease.
Read More...
|

A search engine just for health ?

screenshot_02
One of the issues that consistently comes up when I do research with consumers on the Internet is that they are often overwhelmed with search results. Where do they go? What is credible? Where do they start? It looks like a new website that launched today finally solved that problem. Welcome to Healthbase
Read More...
|

How should big pharma handle newly reported side effects ?

images
What to do in an era of transparency and free flowing information thanks to the Internet. That is a question that a lot of companies are asking themselves right now but the pharmaceutical industry is different from consumer packaged goods because it takes hundreds of millions of dollars to development drugs and the clock can start ticking on patent expiration, and sales, long before the drug is approved for sale. Here is a recommendation as to what to do when patients are consumers of healthcare. Read More...
|

Pay as you live health models ?

ED-AJ652_Burd_D_20090611165004
70% of all health-care costs are the direct result of patient behavior and 74% of all health costs are confined to four chronic conditions (cardiovascular disease, cancer, diabetes and obesity) with 80% of cardiovascular disease and diabetes is preventable, 60% of cancers preventable, and more than 90% of obesity preventable. These statistics are from the CEO of Safeway who is taking action to lower health costs resulting in a four-year period of per capita health-care costs that were flat (that includes both the employee and the employer portion), while most American companies' costs have increased 38% over the same four years. How are they doing this? By using the same model that auto insurance companies use to determine our risk as drivers.
Share/Save/Bookmark Read More...
|

If your agency is telling you to spend more money on search, run away !

28-23_runaway
I usually like the research that Pew Internet publishes but the report on search on health is "duh 101"; We've found consistently in our health surveys that a general search is the first stop for health consumers on the Internet," Fox says. Fox says half of online health queries are for someone else. And women are more likely to conduct health searches than men. If your agency is telling you to spend more money on search because of data like this you need to run away because they should be saying "we've found a way to maximize your search dollars while spending less".
Share/Save/Bookmark Read More...
|

iPhone Application from Sanofi Aventis maybe just the start of new marketing opportunities in DTC

me277
Imagine you're on the road and trying to eat right. Sanofi's GoMeals™ makes it easy to access nutritional information, find restaurants and keep track of your food intake. If you have a health condition like diabetes, knowing information like calories, fats and carbs can be critical. GoMeals was developed to help consumers get the information they need to make better meal choices at home or on the go. This is a great app but this is just the start of a lot of mobile tools to come if pharma can prepare for the future and anticipate the opportunities of mobile apps plus the Apple tablet.
Share/Save/Bookmark Read More...
|

$30,000 a month for a cancer treatment that may not prolong life

articleInline1
The price of the new drug, called Folotyn, is at least triple that of other drugs that critics have said are too expensive for the benefits they offer to patients. The cost is $30,000 a month and while drug companies have the right to set prices to recoup costs the cost of this product is surely going to bring more unneeded attention to the drug industry and their pricing tactics.
Share/Save/Bookmark Read More...
|

Drug companies don't have the luxury of waiting for the FDA to issue guidelines on marketing

toldyouso
So what's wrong with this picture? Drug companies are going to see a lot of big named brands come off patent and in addition it seems that the $80 billion of concessions via the new healthcare bill is not enough for Democrats who want to squeeze the industry like a sponge. So rather than ramp up marketing as they realize that empowered patients are consumers of healthcare they are waiting for an ever cautious Federal agency to issue guidelines that maybe outdated as soon as they are issued?
Share/Save/Bookmark Read More...
|

Regulatory restraints = ignorance of social media and empowered consumers Why DTC marketing is in a funk

ignorance
"The concept and value of the social medium as this unconstrained exchange is not consistent with the regulatory constraints," said Chris Kuenne, CEO of Rosetta Stone. Excuse me but that is wrong on so many levels and shows why the pharma industry is so behind the times when it comes to DTC marketing.



Read More...
|

What's really holding back DTC marketing? Hint: Let's have a meeting to talk about it

images
Change, we all talk about it but implementing change is a hell of a lot harder than you would think. Before you can change though you need to do a self examination of your processes and determine if they are still relevant in a market that demands speed. Way too many drug companies are "matrix organizations" which translates into a lot of meetings and Power Points before you can implement the simplest of actions. Read More...
|

If social media is not the answer, what's the future of DTC ?

iStock_000010976693XSmall
Finally business publications and marketing people are beginning to realize that social media, alone, is not the answer to the riddle of empowered consumers. The fact that so many consumers don't trust the FDA or the the drug industry is just one of the many symptoms that DTC marketing is one very sick patient. So what can marketers do to make DTC marketer relevant again?

Read More...
|

Doctors are increasingly concerned that the sales pitches from drug reps are not giving them the full story

me254
42,000 and counting. That's the number of jobs that have been shed by big pharma this year, mostly in the sales force. Are there more to come? Well, if big pharma wants to maintain a nice healthy profit margin (the biggest by the way of ANY industry) they are going to have to continue to cut costs and at a time when the sales force is becoming less effective I expect a lot more cuts in that area. Read More...
|

More Stuff